Showing results (101-110 of 131) with videos related to

Sort By:
Pageof 14
Modern Rheumatology|October 9, 2009
Cutaneous vasculitis induced by TNF inhibitors: a report of three casesKeita Fujikawa, Atsushi Kawakami, Tomayoshi Hayashi, et al.
Medicine|November 1, 2012
Familial Mediterranean fever in JapanKiyoshi Migita, Ritei Uehara, Yoshikazu Nakamura, et al.
The Journal of Rheumatology|May 19, 2009
High serum cartilage oligomeric matrix protein determines the subset of patients with early-stage rheumatoid arthritis with high serum C-reactive protein, matrix metalloproteinase-3, and MRI-proven bone erosionKeita Fujikawa, Atsushi Kawakami, Mami Tamai, et al.
The Journal of Rheumatology|October 3, 2009
Proinflammatory cytokines synergistically enhance the production of chemokine ligand 20 (CCL20) from rheumatoid fibroblast-like synovial cells in vitro and serum CCL20 is reduced in vivo by biologic disease-modifying antirheumatic drugsShin-Ya Kawashiri, Atsushi Kawakami, Naoki Iwamoto, et al.
Arthritis and Rheumatism|May 30, 2009
A prediction rule for disease outcome in patients with undifferentiated arthritis using magnetic resonance imaging of the wrists and finger joints and serologic autoantibodiesMami Tamai, Atsushi Kawakami, Masataka Uetani, et al.
Plos One|May 15, 2015
Identification of Disease-Promoting HLA Class I and Protective Class II Modifiers in Japanese Patients with Familial Mediterranean FeverMichio Yasunami, Hitomi Nakamura, Kazunaga Agematsu, et al.
The Journal of Laboratory and Clinical Medicine|December 4, 2003
Protection of mitochondrial perturbation by human T-lymphotropic virus type 1 tax through induction of Bcl-xL expressionKoto Nakashima, Atsushi Kawakami, Ayumi Hida, et al.
Clinical and Experimental Rheumatology|October 21, 2011
Soluble urokinase plasminogen activator receptor as a useful biomarker to predict the response to adalimumab in patients with rheumatoid arthritis in a Japanese populationTomohiro Koga, Akitomo Okada, Shinya Kawashiri, et al.
Modern Rheumatology|October 1, 2011
Treatment discontinuation in patients with very early rheumatoid arthritis in sustained simplified disease activity index remission after synthetic disease-modifying anti-rheumatic drug administrationJunko Kita, Mami Tamai, Kazuhiko Arima, et al.
Biochemical and Biophysical Research Communications|November 26, 2003
Akt is an endogenous inhibitor toward tumor necrosis factor-related apoptosis inducing ligand-mediated apoptosis in rheumatoid synovial cellsTaiichiro Miyashita, Atsushi Kawakami, Mami Tamai, et al.
Pageof 14